Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
Vladimir R. Babaev(Vanderbilt University Medical Center), MacRae F. Linton(Vanderbilt University), Sergio Fazio(Alzheimer's Association), Matthew D. Breyer(Johnson & Johnson (United States)), Sarah Davis(Patient Advocate Foundation), Richard Breyer(Vanderbilt University), Lei Ding(Zhejiang University), John A. Oates(Vanderbilt University), Joshua D. Chew(Vanderbilt University)
Cited by 114
Related Papers
Current Perspectives on Statins
|Circulation|2000|1.2k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
|Nature Medicine|2001|692
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
|Journal of Clinical Investigation|1983|671
Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort
|American Journal of Obstetrics and Gynecology|2016|578